TrialAnnals of hematology2024

Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial.

Heng Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.